Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | NVO | JNJ | ||
| Company | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 803.83 | 107.98 | 157.67 | ||
| High | 808.86 | 109.56 | 158.59 | ||
| Low | 797.49 | 107.75 | 156.35 | ||
| Last | 806.00 | 109.26 | 158.01 | ||
| Change | -0.14 | -0.46 | -0.23 | ||
| % Change | -0.02% | -0.42% | -0.15% | ||
| Volume | 1,814,421 | 3,667,955 | 1,989,003 | ||
| 20-Day Average Volume | 3,319,345 | 4,697,521 | 5,826,836 | ||
| Previous Close | 806.14 | 109.72 | 158.24 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 888.05 | 115.19 | 161.89 | ||
| 20-Day Raw Stochastic | 18.95% | 15.28% | 19.62% | ||
| 20-Day Relative Strength | 29.42% | 30.71% | 41.79% | ||
| Weighted Alpha | +22.51 | -3.71 | +6.04 | ||
| Today's Opinion | 24% Sell | 88% Sell | 24% Buy | ||
| Previous Opinion | 24% Sell | 88% Sell | 24% Buy | ||
| Last Month's Opinion | 56% Buy | 72% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.37% since 10/29/24 | -2.42% since 10/29/24 | -1.06% since 10/29/24 | ||
| Low | 769.00 on 10/30/24 | 107.24 on 10/30/24 | 156.35 on 11/05/24 | ||
| High | 860.50 on 10/30/24 | 113.76 on 10/30/24 | 161.28 on 10/30/24 | ||
| 1-Month | |||||
| %Chg | -9.73% since 10/04/24 | -5.08% since 10/04/24 | -1.19% since 10/04/24 | ||
| Low | 769.00 on 10/30/24 | 107.24 on 10/30/24 | 156.35 on 11/05/24 | ||
| High | 937.00 on 10/14/24 | 120.56 on 10/11/24 | 166.75 on 10/15/24 | ||
| 3-Month | |||||
| %Chg | +3.30% since 08/05/24 | -13.27% since 08/05/24 | -1.77% since 08/05/24 | ||
| Low | 763.02 on 08/07/24 | 107.24 on 10/30/24 | 156.35 on 11/05/24 | ||
| High | 972.53 on 08/22/24 | 139.74 on 08/30/24 | 168.85 on 09/04/24 | ||
| 6-Month | |||||
| %Chg | +8.96% since 05/03/24 | -11.19% since 05/03/24 | +6.11% since 05/03/24 | ||
| Low | 736.00 on 05/06/24 | 107.24 on 10/30/24 | 143.71 on 05/29/24 | ||
| High | 972.53 on 08/22/24 | 148.15 on 06/25/24 | 168.85 on 09/04/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 765,281,600 | 492,372,032 | 380,982,272 | ||
| Shares Outstanding, K | 949,316 | 4,487,532 | 2,407,623 | ||
| Annual Sales | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | 11,439,100,000 | 9,821,060,000 | 22,471,000,000 | ||
| Last Quarter Net Income | 970,300,000 | 2,893,220,000 | 2,694,000,000 | ||
| 60-Month Beta | 0.43 | 0.42 | 0.53 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.18 on 10/30/24 | 0.65 on 08/07/24 | 2.42 on 10/15/24 | ||
| Latest Earnings Date | 10/30/24 | 11/06/24 | 10/15/24 | ||
| Most Recent Dividend | 1.300 on 08/15/24 | 0.362 on 08/16/24 | 1.240 on 08/27/24 | ||
| Next Ex-Dividends Date | 11/15/24 | 08/16/24 | 11/26/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 80.52 | 38.34 | 15.64 | ||